A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 4,013 shares of ILMN stock, worth $578,473. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,013
Previous 6,768 40.71%
Holding current value
$578,473
Previous $706,000 25.92%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$105.28 - $135.9 $290,046 - $374,404
-2,755 Reduced 40.71%
4,013 $523,000
Q2 2024

Jul 19, 2024

SELL
$101.05 - $133.57 $2.19 Million - $2.9 Million
-21,690 Reduced 76.22%
6,768 $706,000
Q1 2024

Apr 22, 2024

BUY
$127.73 - $147.2 $2.54 Million - $2.93 Million
19,882 Added 231.83%
28,458 $3.91 Million
Q4 2023

Jan 16, 2024

BUY
$92.79 - $142.53 $146,793 - $225,482
1,582 Added 22.62%
8,576 $1.19 Million
Q3 2023

Oct 24, 2023

SELL
$128.91 - $192.44 $177,509 - $264,989
-1,377 Reduced 16.45%
6,994 $960,000
Q2 2023

Jul 25, 2023

SELL
$183.43 - $232.67 $310,546 - $393,910
-1,693 Reduced 16.82%
8,371 $1.57 Million
Q1 2023

Apr 14, 2023

BUY
$193.75 - $232.55 $581 - $697
3 Added 0.03%
10,064 $2.34 Million
Q4 2022

Feb 08, 2023

BUY
$187.24 - $242.74 $101,858 - $132,050
544 Added 5.72%
10,061 $2.03 Million
Q3 2022

Oct 25, 2022

SELL
$177.23 - $227.44 $230,399 - $295,672
-1,300 Reduced 12.02%
9,517 $1.82 Million
Q2 2022

Aug 12, 2022

SELL
$181.58 - $368.0 $142,540 - $288,880
-785 Reduced 6.77%
10,817 $1.99 Million
Q1 2022

May 11, 2022

BUY
$303.87 - $423.8 $32,210 - $44,922
106 Added 0.92%
11,602 $4.05 Million
Q4 2021

Feb 08, 2022

SELL
$347.28 - $421.83 $17 Million - $20.7 Million
-48,961 Reduced 80.98%
11,496 $4.37 Million
Q3 2021

Nov 02, 2021

BUY
$405.61 - $524.84 $16.9 Million - $21.9 Million
41,750 Added 223.18%
60,457 $24.5 Million
Q2 2021

Aug 11, 2021

SELL
$372.84 - $481.5 $645,386 - $833,476
-1,731 Reduced 8.47%
18,707 $8.85 Million
Q1 2021

May 14, 2021

BUY
$361.28 - $504.76 $240,973 - $336,674
667 Added 3.37%
20,438 $7.85 Million
Q4 2020

Feb 12, 2021

BUY
$292.7 - $370.96 $727,652 - $922,206
2,486 Added 14.38%
19,771 $7.32 Million
Q3 2020

Nov 04, 2020

BUY
$268.51 - $400.74 $905,147 - $1.35 Million
3,371 Added 24.23%
17,285 $5.34 Million
Q2 2020

Jul 17, 2020

SELL
$256.46 - $373.01 $549,593 - $799,360
-2,143 Reduced 13.35%
13,914 $5.15 Million
Q1 2020

Apr 21, 2020

BUY
$209.2 - $335.53 $31,170 - $49,993
149 Added 0.94%
16,057 $4.39 Million
Q4 2019

Feb 12, 2020

BUY
$288.29 - $335.49 $1.13 Million - $1.32 Million
3,924 Added 32.74%
15,908 $5.28 Million
Q3 2019

Nov 07, 2019

SELL
$266.84 - $378.23 $496,589 - $703,886
-1,861 Reduced 13.44%
11,984 $3.65 Million
Q2 2019

Aug 06, 2019

SELL
$300.59 - $368.15 $1.43 Million - $1.75 Million
-4,745 Reduced 25.52%
13,845 $5.1 Million
Q1 2019

May 06, 2019

BUY
$272.57 - $321.18 $467,730 - $551,144
1,716 Added 10.17%
18,590 $5.78 Million
Q4 2018

Feb 11, 2019

BUY
$272.46 - $366.54 $74,109 - $99,698
272 Added 1.64%
16,874 $5.06 Million
Q3 2018

Nov 14, 2018

BUY
$279.04 - $367.06 $310,571 - $408,537
1,113 Added 7.19%
16,602 $6.09 Million
Q2 2018

Jul 30, 2018

BUY
$228.17 - $292.07 $2.02 Million - $2.58 Million
8,835 Added 132.78%
15,489 $4.33 Million
Q1 2018

Apr 16, 2018

BUY
$209.54 - $253.91 $1.39 Million - $1.69 Million
6,654 New
6,654 $1.57 Million
Q4 2017

Feb 09, 2018

SELL
$202.23 - $230.03 $989,713 - $1.13 Million
-4,894 Closed
0 $0
Q3 2017

Oct 26, 2017

SELL
$172.3 - $213.93 $138,529 - $171,999
-804 Reduced 14.11%
4,894 $975,000
Q2 2017

Aug 15, 2017

BUY
N/A
5,698
5,698 $989,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.